Option chain shows key data for Love Hemp Group's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Love Hemp Group.

Love Hemp Group (OTC:WRHLF) Stock, Option Chain

Love Hemp Group PLC is a Cannabidiol and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products.

Cannabis

News

Penny Stocks

Small Cap

Sports

Markets

General

CWBHF

WRHLF

TSX:CWEB

The MLB is the first big-league sports property to officially have a CBD sponsor, a move that will give the league a piece of the growing CBD market in the U.S, estimated to be worth $4.9 billion worldwide this year and 

Major League Baseball Becomes First Big-League Sports Property To Sign CBD Sponsorship Deal

TSCDF

TSCDY

Love Hemp Group PLC (AQSE:LIFE) (OTCQB: WRHLF), the brand-led consumer goods company focused on CBD health and wellness solutions, revealed that TESCO PLC, (OTCQX: TSCDY) (OTCQX: 

Love Hemp Launches CBD Products In UK Tesco Supermarkets

Love Hemp Group PLC (AQSE:LIFE) (OTCQB: WRHLF) has announced its unaudited interim results for the six months ended 31 December 2021.

Love Hemp Interim Financial Results &#39;Disappointing&#39; Chairman Says, As It Looks To Uplist To LSE

LOVE HEMP GROUP PLC by LOVE HEMP GROUP PLC

Love Hemp Group PLC

<p>Wells Fargo  analyst Gary Mobley   initiates coverage on Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Equal-Weight rating and announces Price Target of $570.</p>


Price Target

Initiation

Analyst Ratings

SNPS

Wells Fargo Initiates Coverage On Synopsys with Equal-Weight Rating, Announces Price Target of $570

<p>Morgan Stanley  analyst Natasha Bonnet   initiates coverage on Ermenegildo Zegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZGN#NYSE">ZGN</a>) with a Underweight rating and announces Price Target of $7.2.</p>


Morgan Stanley Initiates Coverage On Ermenegildo Zegna with Underweight Rating, Announces Price Target of $7.2

WIIM

ESTC

Elastic shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY25 guidance above estimates.

<p>Pyxis Tankers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXS#NASDAQ">PXS</a>) reported quarterly earnings of $0.31 per share. This is a 19.23 percent increase over earnings of $0.26 per share from the same period last year.  The company reported quarterly sales of $13.792 million which missed the analyst consensus estimate of $15.150 million by 8.96 percent.  This is a 24.27 percent increase over sales of $11.098 million the same period last year.</p>


Earnings

Earnings Misses

Pyxis Tankers Q3 2024 GAAP EPS $0.31 Up From $0.26 YoY, Sales $13.792M Miss $15.150M Estimate

Tapestry shares are trading higher after the company announced agreements for a $2 billion Accelerated Share Repurchase program.

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">43.94</td>
<td align="right">0.18</td>
<td align="right">0.41</td>
<td>2.8K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">82.21</td>
<td align="right">0.32</td>
<td align="right">0.39</td>
<td>14.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">144.40</td>
<td align="right">0.37</td>
<td align="right">0.25</td>
<td>1.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">215.27</td>
<td align="right">0.27</td>
<td align="right">0.12</td>
<td>183</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">50.22</td>
<td align="right">0.05</td>
<td align="right">0.09</td>
<td>234.5K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">97.00</td>
<td align="right">-0.12</td>
<td align="right">-0.13</td>
<td>9.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.06</td>
<td align="right">-0.03</td>
<td align="right">-0.04</td>
<td>858</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">233.43</td>
<td align="right">-0.05</td>
<td align="right">-0.03</td>
<td>21.7K</td>
</tr>
</tbody>
</table>
<p><a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. </p>
<p><em>For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.</em> </p>


Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For November 22, 2024

<p>Targeting $200B Digital Grocery Market With Key Retailers Like Fareway Stores And Vroom Delivery</p>


PUBM

PubMatic Partners With DIGITS Agency To Monetize Digital Grocery Advertising Through Scalable AdTech Platform

<p>Wells Fargo  analyst Gary Mobley   initiates coverage on Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) with a Overweight rating and announces Price Target of $23.</p>


ALGM

Wells Fargo Initiates Coverage On Allegro Microsystems with Overweight Rating, Announces Price Target of $23

<p>Leerink Partners  analyst Jeffrey La Rosa   initiates coverage on Janux Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JANX#NASDAQ">JANX</a>) with a Outperform rating and announces Price Target of $79.</p>


JANX

Leerink Partners Initiates Coverage On Janux Therapeutics with Outperform Rating, Announces Price Target of $79

<p>Keybanc  analyst Tim Rezvan   maintains Gulfport Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPOR#NYSE">GPOR</a>) with a Overweight and raises the price target from $165 to $205.</p>


GPOR

Keybanc Maintains Overweight on Gulfport Energy, Raises Price Target to $205

APTO

Aptose Biosciences shares are trading lower after the company announced the pricing of an $8 million public offering.

Offerings

Aptose Biosciences Prices $8M Public Offering Of 40M Shares And 20M Warrants At $0.20 Per Unit; Warrants Priced At $0.25 Per Share And Expire In Five Years, With Closing Expected On November 25, 2024

<p>Goldman Sachs  analyst Adam Bubes   initiates coverage on AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) with a Buy rating and announces Price Target of $130.</p>


Goldman Sachs Initiates Coverage On AECOM with Buy Rating, Announces Price Target of $130

<p>Wells Fargo  analyst Joe Quatrochi   initiates coverage on ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Overweight rating and announces Price Target of $155.</p>


Wells Fargo Initiates Coverage On ARM Holdings with Overweight Rating, Announces Price Target of $155

SBFM

Sunshine Biopharma shares are trading higher after its Nora Pharma subsidiary launched Ursodiol, a generic version of URSO DS.

<p>Keybanc  analyst Steve Barger   maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Overweight and raises the price target from $205 to $215.</p>


Keybanc Maintains Overweight on AMETEK, Raises Price Target to $215

<p>Confirmed By Nasdaq Listing Qualifications On November 21, 2024</p>


NDRA

ENDRA Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Rule

Sunshine Biopharma's Nora Pharma Subsidiary Launches Ursodiol, A Generic Version Of URSO DS

<p>Goldman Sachs  analyst Adam Bubes   initiates coverage on EMCOR Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) with a Sell rating and announces Price Target of $445.</p>


Goldman Sachs Initiates Coverage On EMCOR Group with Sell Rating, Announces Price Target of $445

<p>UBS  analyst David Vogt   initiates coverage on Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) with a Neutral rating and announces Price Target of $95.</p>


Comments

Love Hemp Group

Love Hemp Group (WRHLF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga